Načítá se...
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
OBJECTIVE: Recombinant human leptin (metreleptin) improves glycemia and hypertriglyceridemia in patients with generalized lipodystrophy; antibody development with in vitro neutralizing activity has been reported. We aimed to characterize anti-metreleptin antibody development, including in vitro neut...
Uloženo v:
| Vydáno v: | Clin Endocrinol (Oxf) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4875885/ https://ncbi.nlm.nih.gov/pubmed/26589105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.12980 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|